The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase III, randomized, double blind, placebo-controlled trial of sorafenib in desmoid tumors (Alliance A091105).
 
Mrinal M. Gounder
Honoraria - Amgen; Daiichi Sankyo; Epizyme; Karyopharm Therapeutics; TRACON Pharma
Consulting or Advisory Role - Amgen; Daiichi Sankyo; Epizyme; Karyopharm Therapeutics
Speakers' Bureau - Amgen
Travel, Accommodations, Expenses - Amgen; Daiichi Sankyo; Epizyme; Karyopharm Therapeutics
Other Relationship - Desmoid Tumor Research Foundation
 
Michelle R. Mahoney
No Relationships to Disclose
 
Brian Andrew Van Tine
Consulting or Advisory Role - Caris Life Sciences; CytRx Corporation; EMD Serono; Johnson & Johnson; Lilly/ImClone; Novartis; Plexxikon; Threshold Pharmaceuticals
Speakers' Bureau - Caris Life Sciences; Johnson & Johnson; Lilly; Novartis
Research Funding - Merck; Pfizer
Expert Testimony - Me1 Patient
 
Vinod Ravi
No Relationships to Disclose
 
Steven Attia
Research Funding - AB Science (Inst); Bayer (Inst); Bayer (Inst); CytRx Corporation (Inst); Daiichi Sankyo (Inst); Dicephera Pharmaceuticals, Inc. (Inst); Epizyme (Inst); Immune Design (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Novartis (Inst); Novartis (Inst); TRACON Pharma (Inst)
Travel, Accommodations, Expenses - Immune Design
 
Hari Anant Deshpande
Honoraria - Lilly
Consulting or Advisory Role - Eisai
Speakers' Bureau - Lilly
Travel, Accommodations, Expenses - Lilly
 
Abha A. Gupta
No Relationships to Disclose
 
Mohammed M. Milhem
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; EMD Serono; Genentech/Roche; Novartis
 
Robert Martin Conry
Speakers' Bureau - Bristol-Myers Squibb; Merck; Novartis
 
Sujana Movva
Research Funding - Novartis (Inst); Takeda (Inst)
 
Michael J. Pishvaian
Stock and Other Ownership Interests - Perthera
Honoraria - Caris Life Sciences; Celgene; Merrimack; Sirtex Medical
Consulting or Advisory Role - AstraZeneca/MedImmune; Caris Life Sciences; Celgene; Perthera; RenovoRx; Sirtex Medical
Research Funding - ARMO BioSciences (Inst); Bavarian Nordic (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Calithera Biosciences (Inst); Celgene (Inst); Celldex (Inst); Curegenix (Inst); FibroGen (Inst); Genentech (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Halozyme (Inst); Karyopharm Therapeutics (Inst); MedImmune (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Pharmacyclics (Inst); Regeneron (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Caris Life Sciences; Perthera; Sirtex Medical
 
Jeffrey Crawford
Consulting or Advisory Role - AstraZeneca; BeyondSpring Pharmaceuticals; Celgene; Dova Pharmaceuticals; G1 Therapeutics; Janssen; Merck; Merrimack; Mylan; Pfizer; Roche
Research Funding - Amgen (Inst); AstraZeneca (Inst); Bayer (Inst); Genentech (Inst)
 
Tarek Sabagh
Honoraria - Cardinal Health; Teva
Speakers' Bureau - Bristol-Myers Squibb
 
Robert G. Maki
Honoraria - Lilly; Springer; Wiley
Consulting or Advisory Role - AADi; American Board of Internal Medicine (ABIM); Arcus Ventures; Bayer; Deciphera; Eisai; Immune Design; Karyopharm Therapeutics; Lilly/ImClone; Presage Biosciences; SARC: Sarcoma Alliance for Research though Collaboration; TRACON Pharma
Research Funding - Daiichi Sankyo (Inst); Immune Design (Inst); Immunocore (Inst); Lilly (Inst); Presage Biosciences (Inst); Regeneron (Inst); TRACON Pharma (Inst); Xencor (Inst)
Patents, Royalties, Other Intellectual Property - Uptodate: I write and edit chapters for their online text book.
Travel, Accommodations, Expenses - TRACON Pharma
 
William D. Tap
Consulting or Advisory Role - Adaptimmune; Blueprint Medicines; Daiichi Sankyo; Eisai; EMD Serono; Immune Design; Janssen; Lilly; Loxo; Novartis; Plexxikon; TRACON Pharma
 
Robert A Lefkowitz
No Relationships to Disclose
 
Narasimhan P Agaram
No Relationships to Disclose
 
John Joseph Wright
No Relationships to Disclose
 
Amylou C. Dueck
Consulting or Advisory Role - Bayer; Bayer; Bayer
Travel, Accommodations, Expenses - Pfizer
 
Gary K. Schwartz
Honoraria - BioMotiv; Bionaut Labs; Champions Oncology; Daiichi Sankyo; DarwinHealth; Human Longevity, Inc; Karyopharm Therapeutics
Consulting or Advisory Role - BioMotiv; Bionaut Labs; Champions Oncology; Daiichi Sankyo; DarwinHealth; Human Longevity, Inc; Karyopharm Therapeutics; PureTech
Research Funding - Astex Pharmaceuticals
Patents, Royalties, Other Intellectual Property - Patent pending regarding development of PNAs for targeted cancer therapy (new technology)
Travel, Accommodations, Expenses - Daiichi Sankyo